A proposed new model for prognostic stratification of poor-risk patients with metastatic renal cell carcinoma (mRCC) in the era of targeted therapy. This is an ASCO Meeting Abstract from the 2014 ASCO ...
Genetic polymorphisms’ influence in outcome of metastatic renal cell cancer patients treated with VEGF-targeted agents. Longitudinal serum testosterone levels (T) in long-term testicular cancer ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results